College of Korean Medicine, Kyung Hee University, Kyungheedae-ro 26 Dongdaemun-gu, Seoul 02447, Korea.
Laboratory of Experimental Pathology, Federal University of São João del Rei-CCO/UFSJ, Divinópolis 35501-296, Brazil.
Nutrients. 2022 Oct 12;14(20):4252. doi: 10.3390/nu14204252.
Primary liver cancer was the seventh most diagnosed cancer and the second leading cause of cancer death with about 906,000 cases and 830,000 deaths, respectively, in 2020. Conventional treatment for liver cancer, such as transarterial chemoembolization (TACE) or sorafenib, has limitations in that there is the recurrence of cancer, drug inefficacy, and adverse effects. Traditional medicine and natural products of several regions including Korea, China, Europe, North America, India, and the Middle East have attracted a lot of attention since they have been reported to have anticancer effects with low adverse effects. In this review, several in vivo studies on the effects of natural compounds on liver cancer and clinical trials approving their therapeutic benefits were selected and discussed. As a result of the analysis of these studies, the effects of natural compounds were classified into a few mechanisms: apoptosis, anti-metastasis, and antiangiogenesis. In addition, medications including natural products in clinical trials were observed to exhibit improvements in various liver cancer symptoms and patients' survival rates. This study presents findings suggestive of the anticancer potential of natural products and their properties in relieving related symptoms.
2020 年,原发性肝癌是全球第七大常见癌症,也是癌症死亡的第二大主要原因,分别有 90.6 万例和 83 万例。肝癌的常规治疗方法,如经动脉化疗栓塞(TACE)或索拉非尼,存在一些局限性,如癌症复发、药物无效和不良反应等。包括韩国、中国、欧洲、北美、印度和中东在内的几个地区的传统医学和天然产品,由于具有抗癌作用且不良反应低,引起了广泛关注。在本综述中,选择并讨论了几项关于天然化合物对肝癌影响的体内研究和批准其治疗益处的临床试验。通过对这些研究的分析,天然化合物的作用被分为几种机制:细胞凋亡、抗转移和抗血管生成。此外,临床试验中包括天然产品在内的药物观察到可改善各种肝癌症状和患者生存率。本研究表明天然产物具有抗癌潜力及其缓解相关症状的特性。